VASOOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
VASO Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.29+0.00 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $51.17M
- P/E (TTM)
- 29.0
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
VASO has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements VASO filed with the SEC
NOVEMBER 19, 2025 PRESS RELEASE
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED SEPTEMBER 18, 2024
Agreement terminated · Other events · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Other events · EX-99.1 to Form 8-K
Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K